In this micro learning module, developed by experts Prof. Alison Layton and Prof. Dr Falk Ochsendorf, you will explore multimodal treatment strategies for

In this micro learning, developed by experts Assoc. Prof. Lorenza Rimassa and Dr Amit Singal, you will learn about treatment strategies for patients who

In this conference update video, Profs. Wolfgang Janni, Sherko Kümmel and Michail Ignatiadis provide key insights from the highly anticipated ESMO Breast

Metastatic pancreatic ductal adenocarcinoma (mPDAC) is notoriously aggressive, with a poor prognosis. It is often diagnosed late, and by this time,

In this 2-part video animated series, medical oncologists Prof Eileen O’Reilly and Prof Efrat Dotan provide an overview of the different treatment options

This is the second episode of a two-part series on the HER2 diagnostic and treatment landscape in non-small cell lung cancer (NSCLC), hosted by the

This is the first episode of a two-part series on the HER2 diagnostic and treatment landscape in non-small cell lung cancer (NSCLC), hosted by the

Access the paper online here: The Evolving Role of the Oncology Nurse in the United States of America.   The survey results highlight:  How roles and

In this micro learning developed by experts Prof. Aiwu Ruth He and Prof. Beau Toskich, you’ll learn about the expanding role of immunotherapy (IO) in

Prof. François-Clément Bidard and Dr Barbara Pistilli share expert insights on the latest TROPION-Breast01 update, presenting the final OS results from

Discover insights from the Phase 3 LEAP-012 study evaluating lenvatinib + pembrolizumab + TACE versus double placebo + TACE for patients with intermediate

In this conference update video, Profs. Shaheenah Dawood, Heather McArthur, Javier Cortés, and Frédérique Penault-Llorca provide key insights from the

Join Dr Rena Callahan and Dr Roberto Salgado as they explore the latest insights in molecular testing and targeted therapy for HR+/HER2- metastatic breast

In this conference update video, Profs. Michael Gnant and Giuseppe Curigliano provide key insights from the highly anticipated 19th St. Gallen Breast

The treatment landscape for advanced and recurrent endometrial cancer (EC) is evolving, with molecular classification playing a key role in guiding